Martine and Jean-Paul Clozel, the star couple of the world pharmacy - News in France
CEO Daily: Thursday, 26th January | Fortune
Profile: Jean-Paul Clozel | Nature Biotechnology
Les français les plus fortunés de Suisse : les surprises du classement - Challenges
5 éditeurs parmi les 500 plus grandes fortunes de France - Livres Hebdo
Deux stars de la biotech suisse réussissent une brillante entrée en bourse | 24 heures
Jean-Paul Clozel - CEO, Idorsia - PharmaBoardroom
Jean-Paul Clozel | EY - Global
Molecular Millionaire: Jean-Paul Clozel of Actelion
Speakers – Swiss HLG Winter Conference 2018 | by organizers.ch
La Suisse a vu, en 2017, plus de milliardaires partir qu'arriver - SWI swissinfo.ch
PharmaBoardroom - Jean-Paul Clozel - CEO & Co-Founder, Actelion, Switzerland
Bilanz 300 Reichste 2022: Jean-Paul und Martine Clozel | BILANZ
Les 500 plus grandes fortunes de France en 2022 - Challenges
From Actelion to Idorsia: The entrepreneurial journey of Jean-Paul Clozel & Martine Clozel
Les 500 plus grandes fortunes de France en 2022 - Challenges
Jean-Paul Clozel
Who wants to be a billionaire? Not Actelion's founder and CEO, if it means selling out | Fierce Pharma
World Entrepreneur 2008Dr Jean -Paul Clozel with wife Mart… | Flickr
Idorsia Business Report 2020
Johnson & Johnson's $30 Billion Actelion Deal Is Finally Happening | Fortune
Jean-Paul Clozel
Forbes USA March 2018 by Omar Estrada - Issuu
Idorsia will take three to four years to reach profitability, CEO says
